EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 105 filers reported holding EPIZYME INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,000 | -90.9% | 522 | -44.2% | 0.00% | – |
Q3 2020 | $11,000 | -80.4% | 935 | -73.0% | 0.00% | – |
Q2 2020 | $56,000 | -96.5% | 3,457 | -96.6% | 0.00% | -100.0% |
Q1 2020 | $1,599,000 | +130.7% | 103,115 | +265.9% | 0.01% | +150.0% |
Q4 2019 | $693,000 | +11450.0% | 28,179 | +4905.2% | 0.00% | – |
Q3 2019 | $6,000 | -99.1% | 563 | -99.0% | 0.00% | -100.0% |
Q2 2019 | $699,000 | +6890.0% | 55,720 | +7080.4% | 0.00% | – |
Q1 2019 | $10,000 | +100.0% | 776 | +0.9% | 0.00% | – |
Q4 2018 | $5,000 | -58.3% | 769 | -31.9% | 0.00% | – |
Q3 2018 | $12,000 | -98.9% | 1,130 | -98.6% | 0.00% | -100.0% |
Q2 2018 | $1,089,000 | +143.1% | 80,358 | +218.6% | 0.00% | +200.0% |
Q1 2018 | $448,000 | +1393.3% | 25,223 | +951.4% | 0.00% | – |
Q4 2017 | $30,000 | -96.3% | 2,399 | -94.4% | 0.00% | -100.0% |
Q3 2017 | $820,000 | -39.3% | 43,020 | -51.9% | 0.00% | -50.0% |
Q2 2017 | $1,352,000 | +408.3% | 89,505 | +477.6% | 0.00% | +300.0% |
Q1 2017 | $266,000 | – | 15,496 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |